While men generally have a low risk of developing breast cancer, BRCA2 mutations raise that risk substantially, and they also increase the likelihood of developing prostate cancer, potentially at a younger age and with more aggressive forms. This evidence concerns the gene BRCA2 and prostate carcinoma.